Document:

exv4w6

Exhibit 4.6

	THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR
TO 5:00 P.M. NEW YORK CITY TIME, MAY, 2015 WARRANTS
W REGENERX BIO PHARMACEUTICALS, INC.
WARRANT CERTIFICATE CUSIP 75886X 11 6

 

 

SUBSCRIPTION FORM

To Be Executed by the Registered Holder in Order to Exercise Warrants

     The undersigned Registered Holder
irrevocably elects to exercise                  
    Warrants
represented by this Warrant Certificate, and to purchase the shares of Common Stock issuable upon
the exercise of such Warrants, and requests that Certificates for such shares shall be issued in
the name of

 

(PLEASE TYPE OR PRINT NAME AND ADDRESS)

 

 

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

and be delivered to

 

(PLEASE TYPE OR PRINT NAME AND ADDRESS)

 

and, if such number of Warrants shall not be all the Warrants evidenced by this Warrant
Certificate, that a new Warrant Certificate for the balance of such Warrants be registered in the
name of, and delivered to, the Registered Holder at the address stated below:

	 	 	 	 	 

	Dated:
	 	 	 	 
	 

	 	 	 	(Signature)
	 
	 	 	 	 
	 

	 	 	 	(Address)
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	(Tax Identification Number)

Signature Guaranteed:         
                      
         

THE SIGNATURE TO THE SUBSCRIPTION FORM MUST CORRESPOND TO THE NAME WRITTEN UPON THE
FACE OF THIS
WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE
WHATSOEVER, AND MUST BE GUARANTEED BY A COMMERCIAL BANK OR TRUST COMPANY OR A MEMBER FIRM OF THE
AMERICAN STOCK EXCHANGE, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE OR CHICAGO STOCK
EXCHANGE.

ASSIGNMENT

To Be Executed by the Registered Holder in Order to Assign Warrants

FOR VALUE RECEIVED,
                                                                                                                         
hereby sell, assign and transfer unto

 

(PLEASE TYPE OR PRINT NAME AND ADDRESS)

 

 

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

and be delivered to

 

(PLEASE PRINT OR TYPE NAME AND ADDRESS)

                                                            
of the Warrants represented by this Warrant Certificate, and hereby irrevocably constitute
and appoint

 

Attorney to transfer this Warrant Certificate on the books of the Company, with full power of
substitution in the premises.

	 	 	 	 	 

	Dated:
	 	 	 	 
	 

	 	 	 	Signature

Signature Guaranteed:            
                        
     

THE SIGNATURE TO THE ASSIGNMENT OF THE SUBSCRIPTION FORM MUST CORRESPOND TO THE NAME WRITTEN
UPON THE FACE OF THIS WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR
ANY CHANGE WHATSOEVER, AND MUST BE GUARANTEED BY A COMMERCIAL BANK OR TRUST COMPANY OR A MEMBER
FIRM OF THE AMERICAN STOCK EXCHANGE, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE OR CHICAGO
STOCK EXCHANGE.exv4w7

Exhibit 4.7

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY
NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN
EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER
APPLICABLE SECURITIES LAWS, OR (2) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED.

REGENERX BIOPHARMACEUTICALS, INC.

WARRANT

         
            Common Shares

May ___, 2010

     This WARRANT (this “Warrant”) of RegeneRx Biopharmaceuticals, Inc., a corporation duly
organized and validly existing under the laws of the State of Delaware (the “Company”), is being
issued pursuant to that certain Underwriting Agreement, dated as of May ___, 2010, by and between
the Company and Maxim Group LLC, the representative of the underwriters (the “Representative”)
relating to a firm commitment public offering (the “Offering”) of an aggregate of      
                units,
each unit consisting of (i) one share of common stock, par value of $0.001 of the Company (each a
“Common Share” and collectively, the “Common Shares”) and (ii) ___Warrants to purchase one Common
Share.

     FOR VALUE RECEIVED, the Company hereby grants to Maxim Group LLC and its permitted successors
and assigns (collectively, the “Holder”) the right to purchase from the Company up to                     
(                    ) Common Shares (such Common Shares underlying this Warrant, the “Warrant Shares”), at
a per share purchase price equal to $___ (the “Exercise Price”), subject to the terms,
conditions, and adjustments set forth below in this Warrant.

     1. Vesting of Warrant. This Warrant shall vest and become exercisable on the six (6)
month anniversary of the Base Date (the “Vesting Date”). For purposes of this Warrant, the “Base
Date” shall mean May ___, 2010. Except as otherwise provided for herein or as permitted by
applicable rules of the Financial Industry Regulatory Authority (“FINRA”), this Warrant shall not
be sold, transferred, assigned, pledged, or hypothecated prior to the Vesting Date.

     2. Expiration of Warrant. This Warrant shall expire on the five (5) year anniversary
of the Base Date (the “Expiration Date”).

 

 

     3. Exercise of Warrant. This Warrant shall be exercisable pursuant to the terms of
this Section 3.

          3.1 Manner of Exercise.

          (a) This Warrant is exercisable in whole or in part at any time and from time to time. Such
exercise shall be effectuated by submitting to the Company (either by delivery to the Company or by
facsimile transmission as provided in Section 12 hereof) a completed and duly executed Notice of
Exercise (substantially in the form attached as Exhibit A hereto) as provided in this
paragraph. The date such Notice of Exercise is faxed or delivered to the Company shall be the
“Exercise Date,” provided that the Holder of this Warrant tenders this Warrant Certificate to the
Company within five (5) Business Days thereafter. As used in this Warrant, “Business Day” shall
mean any day other than a Saturday, Sunday, or any day on which the major stock exchanges in New
York, New York are not open for business. The Notice of Exercise shall be executed by the Holder
of this Warrant and shall indicate the number of Warrant Shares then being purchased pursuant to
such exercise. Upon surrender of this Warrant Certificate, together with appropriate payment of the
Exercise Price for the Warrant Shares purchased, the Holder shall be entitled to receive a
certificate or certificates for the Common Shares so purchased. The Exercise Price may be paid in
a “cashless” or “cash” exercise or a combination thereof pursuant to Section 3.1(b) and Section
3.1(c) below.

          (b) If the Notice of Exercise form elects a “cashless” exercise, the Holder shall thereby be
entitled to receive a number of Common Shares determined as follows:

          X
= Y [(A – B)/A]

          where:

          X = the number of Warrant Shares to be issued to the Holder.

          Y = the number of Warrant Shares with respect to which this Warrant is being
exercised.

          A = the Fair Market Value

          B = the Exercise Price.

          For purposes of this Section 3.1(b), “Fair Market Value” shall be the closing price of the
Common Shares as reported by the OTC Bulletin Board, or if listed on a national securities exchange
or quoted on an automated quotation service, such national securities exchange or automated
quotation service, on the date immediately prior to the Exercise Date. If the Common Shares are
not then listed on a national stock exchange or quoted on the OTC Bulletin Board or such other
quotation system or association, the Fair Market Value of one Common Share as of the date of
determination, shall be as determined in good faith by the Board of Directors of the Company and
the Holder. If the Common Shares are not then listed on a national securities exchange, the OTC
Bulletin Board or such other quotation system or association, the Board of Directors of the Company
shall respond promptly, in writing, to an inquiry by the Holder prior to the exercise hereunder as
to the fair market value of an Common

2

 

Share as determined by the Board of Directors of the Company. In the event that the Board of
Directors of the Company and the Holder are unable to agree upon the fair market value, the Company
and the Holder shall jointly select an appraiser who is experienced in such matters. The decision
of such appraiser shall be final and conclusive, and the cost of such appraiser shall be borne
equally by the Company and the Holder.

          (c) If the Notice of Exercise form elects a “cash” exercise, the Exercise Price per Common
Share for the shares then being exercised shall be payable in cash or by certified or official bank
check.

          3.2 When Exercise Effective. Each exercise of this Warrant shall be deemed to have
been effected immediately prior to the close of business on the Business Day on which this Warrant
shall have been duly surrendered to the Company, and at such time the Holder in whose name any
certificate or certificates for Warrant Shares shall be issuable upon exercise as provided in
Section 3.3 hereof shall be deemed to have become the Holder or Holders of record thereof of the
number of Warrant Shares purchased upon exercise of this Warrant.

          3.3 Delivery of Common Share Certificates and New Warrant. As soon as reasonably
practicable after each exercise of this Warrant, in whole or in part, and in any event within five
(5) Business Days thereafter, the Company, at its expense (including the payment by it of any
applicable issue taxes), will cause to be issued in the name of and delivered to the Holder hereof
or, subject to Sections 9 and 10 hereof, as the Holder (upon payment by the Holder of any
applicable transfer taxes) may direct:

          (a) a certificate or certificates (with appropriate restrictive legends, as applicable) for
the number of duly authorized, validly issued, fully paid, and nonassessable Common Shares to which
the Holder shall be entitled upon exercise; and

          (b) in case exercise is in part only, a new Warrant document of like tenor, dated the date
hereof, for the remaining number of Warrant Shares issuable upon exercise of this Warrant after
giving effect to the partial exercise of this Warrant (including the delivery of any Warrant Shares
as payment of the Exercise Price for such partial exercise of this Warrant).

     4. Certain Adjustments. For so long as this Warrant is outstanding:

          4.1 Mergers or Consolidations. If at any time after the date hereof there shall be a
capital reorganization (other than a combination or subdivision of the Common Shares otherwise
provided for herein) resulting in a reclassification to or change in the terms of securities
issuable upon exercise of this Warrant (a “Reorganization”), or a merger or consolidation of the
Company with another corporation, association, partnership, organization, business, individual,
government or political subdivision thereof or a governmental agency (a “Person” or the “Persons”)
(other than a merger with another Person in which the Company is a continuing corporation and which
does not result in any reclassification or change in the terms of securities issuable upon exercise
of this Warrant or a merger effected exclusively for the purpose of changing the domicile of the
Company) (a “Merger”), then, as a part of such Reorganization or Merger, lawful provision and
adjustment shall be made so that the Holder shall thereafter be entitled to receive, upon exercise
of this Warrant, the number of shares of stock or any other

3

 

equity or debt securities or property receivable upon such Reorganization or Merger by a
holder of the number of Common Shares which might have been purchased upon exercise of this Warrant
immediately prior to such Reorganization or Merger. In any such case, appropriate adjustment shall
be made in the application of the provisions of this Warrant with respect to the rights and
interests of the Holder after the Reorganization or Merger to the end that the provisions of this
Warrant (including adjustment of the Exercise Price then in effect and the number of Warrant
Shares) shall be applicable after that event, as near as reasonably may be, in relation to any
shares of stock, securities, property or other assets thereafter deliverable upon exercise of this
Warrant. The provisions of this Section 4.1 shall similarly apply to successive Reorganizations
and Mergers.

          4.2 Splits and Subdivisions; Dividends. In the event the Company should at any time
or from time to time effectuate a split or subdivision of the outstanding Common Shares or pay a
dividend in or make a distribution payable in additional Common Shares or other securities or
rights convertible into, or entitling the holder thereof to receive, directly or indirectly,
additional Common Shares (hereinafter referred to as the “Common Share Equivalents”) without
payment of any consideration by such holder for the additional Common Shares or Common Shares
Equivalents (including the additional Common Shares issuable upon conversion or exercise thereof),
then, as of the applicable record date (or the date of such distribution, split or subdivision if
no record date is fixed), the per share Exercise Price shall be appropriately decreased and the
number of Warrant Shares shall be appropriately increased in proportion to such increase (or
potential increase) of outstanding shares; provided, however, that no adjustment shall be made in
the event the split, subdivision, dividend or distribution is not effectuated. Notwithstanding the
foregoing or anything else to the contrary herein, in no event shall the per share Exercise Price
be reduced below the par value of one Common Share or of such other securities as may be issued
upon exercise of the Warrant.

          Pursuant to the anti-dilution terms of this Section 4.2, provided that the public shareholders
are proportionally affected by such split or subdivision, dividend, distribution, or other similar
event, the Representative may receive a greater number of Warrant Shares or the per share Exercise
Price may be lower than originally contemplated by this Warrant. Additionally, the Representative
shall not have the right to accrue cash dividends prior to the exercise or conversion of the
Warrant.

          4.3 Combination of Shares. If the number of Common Shares outstanding at any time
after the date hereof is decreased by a combination of the outstanding Common Shares, the per share
Exercise Price shall be appropriately increased and the number of shares of Warrant Shares shall be
appropriately decreased in proportion to such decrease in outstanding shares.

          4.4 Adjustments for Other Distributions. In the event the Company shall declare a
distribution payable in securities of other Persons, evidences of indebtedness issued by the
Company or other Persons, assets (excluding cash dividends or distributions to the holders of
Common Stock paid out of current or retained earnings and declared by the Company’s Board of
Directors) or options or rights not referred to in Sections 4.1, 4.2, or 4.3, then, in each such
case for the purpose of this Section 4.4, upon exercise of this Warrant, the Holder shall be
entitled to a proportionate share of any such distribution as though the Holder was the actual
record holder of

4

 

the number of Warrant Shares as of the record date fixed for the determination of the holders
of Common Shares of the Company entitled to receive such distribution.

     5. No Impairment. The Company will not, by amendment of its certificate of
incorporation or by-laws or through any consolidation, Merger, Reorganization, transfer of assets,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all times in good faith
assist in the carrying out of all of the terms and in the taking of all actions necessary or
appropriate to protect the rights of the Holder against impairment.

     6. Chief Financial Officer’s Report as to Adjustments. With respect to each
adjustment pursuant to Section 4 of this Warrant, the Company, at its expense, will promptly
compute the adjustment or re-adjustment in accordance with the terms of this Warrant and cause its
Chief Financial Officer to certify the computation (other than any computation of the fair value of
property of the Company) and prepare a report setting forth, in reasonable detail, the event
requiring the adjustment or re-adjustment and the amount of such adjustment or re-adjustment, the
method of calculation thereof and the facts upon which the adjustment or re-adjustment is based,
and the Exercise Price and the number of Warrant Shares or other securities purchasable hereunder
after giving effect to such adjustment or re-adjustment, which report shall be mailed by first
class mail, postage prepaid to the Holder. The Company will also keep copies of all reports at its
office maintained pursuant to Section 10.2(a) hereof and will cause them to be available for
inspection at the office during normal business hours upon reasonable notice by the Holder or any
prospective purchaser of the Warrant designated by the Holder thereof.

     7. Reservation of Shares. The Company shall, solely for the purpose of effecting the
exercise of this Warrant, at all times during the term of this Warrant, reserve and keep available
out of its authorized Common Shares, free from all taxes, liens, and charges with respect to the
issue thereof and not subject to preemptive rights or other similar rights of shareholders of the
Company, such number of its Common Shares as shall from time to time be sufficient to effect in
full the exercise of this Warrant. If at any time the number of authorized but unissued Common
Shares shall not be sufficient to effect in full the exercise of this Warrant, in addition to such
other remedies as shall be available to Holder, the Company will promptly take such corporate
action as may, in the opinion of its counsel, be necessary to increase the number of authorized but
unissued Common Shares to such number of shares as shall be sufficient for such purposes, including
without limitation, using its best efforts to obtain the requisite shareholder approval necessary
to increase the number of authorized Common Shares. The Company hereby represents and warrants
that all Common Shares issuable upon exercise of this Warrant shall be duly authorized and, when
issued and paid for upon exercise, shall be validly issued, fully paid and nonassessable.

     8. Registration and Listing.

          8.1 Definition of Registrable Securities; Majority. As used herein, the term
“Registrable Securities” means any Common Shares issuable upon the exercise of this Warrant, until
the date (if any) on which such shares shall have been transferred or exchanged and new
certificates for them not bearing a legend restricting further transfer shall have been delivered
by

5

 

the Company and subsequent disposition of them shall not require registration or qualification
of them under the Securities Act or any similar state law then in force. For purposes of this
Warrant, the term “Majority”, in reference to the holders of Registrable Securities, shall mean in
excess of fifty percent (50%) of the then outstanding Registrable Securities (assuming the exercise
of the entire Warrant) that (i) are not held by the Company, an affiliate, officer, creditor,
employee or agent thereof or any of their respective affiliates, members of their family, Persons
acting as nominees or in conjunction therewith and (ii) have not be resold to the public pursuant
to a registration statement filed under the Securities Act.

          8.2 Required Registration.

          (a) At any time on or after the six (6) month anniversary of the Base Date and on or before
the five (5) year anniversary of the Base Date, but in no event on more than two (2) occasions (the
Registration Expenses associated with second required registration effected (as described in
Section 8.2(c)) pursuant to this Section 8.2(a) shall be payable by the Holder pursuant to Section
8.6), upon the written request of the holders of the Registrable Securities representing a Majority
of such securities, the Company will use its best efforts to effect the registration of the
respective shares of the holders of Registrable Securities under the Securities Act to the extent
requisite to permit the disposition thereof as expeditiously as reasonably possible, but in no
event later than one hundred-twenty (120) days from the date of such request.

          (b) Registration of Registrable Securities under this Section 8.2 shall be on such appropriate
registration form: (i) as shall be selected by the Company, and (ii) as shall permit the
disposition of such Registrable Securities in accordance with this Section 8.2. The Company agrees
to include in any such registration statement all information which the requesting holders of
Registrable Securities shall reasonably request, which is required to be contained therein. The
Company will pay all Registration Expenses in connection with the first, and only the first,
required registration of Registrable Securities effected (as described in Section 8.2(c)) pursuant
to this Section 8.2.

          (c) A registration requested pursuant to this Section 8.2 shall not be deemed to have been
effected: (i) unless a registration statement with respect thereto has become effective or (ii) if,
after it has become effective, such registration is interfered with by any stop order, injunction
or other order or requirement of the Securities and Exchange Commission (the “SEC”) or other
governmental agency or court of competent jurisdiction for any reason, other than by reason of some
act or omission by a holder of Registrable Securities.

          8.3 Incidental Registration Rights.

          (a) If the Company, at any time on or after the six (6) month anniversary of the Base Date and
on or before the five (5) year anniversary of the Base Date, proposes to register any of its
securities under the Securities Act (other than in connection with a registration on Form S-4 or
S-8 or any successor forms) whether for its own account or for the account of any holder or holders
of its shares other than Registrable Securities (any shares of such holder or holders (but not
those of the Company and not Registrable Securities) with respect to any registration are referred
to herein as, “Other Shares”), each such time the Company shall give

6

 

prompt (but not less than thirty (30) days prior to the anticipated effectiveness thereof)
written notice to the holders of Registrable Securities of its intention to do so. Upon the
written request of any such holder of Registrable Securities made within twenty (20) days after the
receipt of any such notice (which request shall specify the Registrable Securities intended to be
disposed of by such holder), except as set forth in Section 8.3(b), the Company will use its best
efforts to effect the registration under the Securities Act of all of the Registrable Securities
which the Company has been so requested to register by such holder, to the extent requisite to
permit the disposition of the Registrable Securities so to be registered, by inclusion of such
Registrable Securities in the registration statement which covers the securities which the Company
proposes to register; provided, however, that if, at any time after giving written
notice of its intention to register any securities and prior to the effective date of the
registration statement filed in connection with such registration, the Company shall determine for
any reason in its sole discretion either to not register, to delay or to withdraw registration of
such securities, the Company may, at its election, give written notice of such determination to
such holder and, thereupon, (i) in the case of a determination not to register, shall be relieved
of its obligation to register any Registrable Securities in connection with such registration (but
not from its obligation to pay the Registration Expenses in connection therewith), without
prejudice, however, to the rights of the holders of Registrable Securities entitled to request that
such registration be effected as a registration under Section 8.2, (ii) in the case of a
determination to delay registration, shall be permitted to delay registering any Registrable
Securities for the same period as the delay in registering such other securities (including the
Other Shares), without prejudice, however, to the rights of the holders of Registrable Securities
entitled to request that such registration be effected as a registration under Section 8.2 and
(iii) in the case of a determination to withdraw registration, shall be permitted to withdraw
registration, without prejudice, however, to the rights of the holders of Registrable Securities
entitled to request that such registration be effected as a registration under Section 8.2. No
registration effected under this Section 8.3 shall relieve the Company of its obligation to effect
any registration upon request under Section 8.2, nor shall any such registration hereunder be
deemed to have been effected pursuant to Section 8.2. The Company will pay all Registration
Expenses in connection with each registration of Registrable Securities pursuant to this Section
8.3.

          (b) If the Company at any time proposes to register any of its securities under the Securities
Act as contemplated by this Section 8.3 and such securities are to be distributed by or through one
or more underwriters, the Company will, if requested by a holder of Registrable Securities, use its
best efforts to arrange for such underwriters to include all the Registrable Securities to be
offered and sold by such holder among the securities to be distributed by such underwriters,
provided that if the managing underwriter of such underwritten offering shall inform the Company by
letter of its belief that inclusion in such distribution of all or a specified number of such
securities proposed to be distributed by such holders of Registrable Securities or Other Shares
would interfere with the successful marketing of the securities being distributed by the Company
(such letter to state the basis of such belief and the approximate number of such Registrable
Securities, such Other Shares and shares held by the Company proposed so to be registered which may
be distributed without such effect) (the “Underwriter’s Letter”), then the Company may, upon
written notice to such holder, the other holders of Registrable Securities, and holders of such
Other Shares, reduce pro rata in accordance with the number of Common Shares desired to be included
in such registration (if and to the extent stated by such managing

7

 

underwriter to be necessary to eliminate such effect) the number of such Registrable
Securities and Other Shares the registration of which shall have been requested by each holder
thereof so that the resulting aggregate number of such Registrable Securities and Other Shares so
included in such registration, together with the number of securities to be included in such
registration for the account of the Company, shall be equal to the number of shares stated in the
Underwriter’s Letter.

          8.4 Registration Procedures. Whenever the holders of Registrable Securities have
properly requested that any Registrable Securities be registered pursuant to the terms of this
Warrant, the Company shall use its best efforts to effect the registration and the sale of such
Registrable Securities in accordance with the intended method of disposition thereof, and pursuant
thereto the Company shall as expeditiously as possible:

          (a) prepare and file with the SEC a registration statement with respect to such Registrable
Securities and use its best efforts to cause such registration statement to become effective;

          (b) notify such holders of the effectiveness of each registration statement filed hereunder
and prepare and file with the SEC such amendments and supplements to such registration statement
and the prospectus used in connection therewith as may be necessary to (i) keep such registration
statement effective and the prospectus included therein usable for a period commencing on the date
that such registration statement is initially declared effective by the SEC and ending on the date
when all Registrable Securities covered by such registration statement have been sold pursuant to
the registration statement or cease to be Registrable Securities, and (ii) comply with the
provisions of the Securities Act with respect to the disposition of all securities covered by such
registration statement during such period in accordance with the intended methods of disposition by
the sellers thereof set forth in such registration statement;

          (c) furnish to such holders such number of copies of such registration statement, each
amendment and supplement thereto, the prospectus included in such registration statement (including
each preliminary prospectus) and such other documents as such seller may reasonably request to
facilitate the disposition of the Registrable Securities owned by such holders;

          (d) use its best efforts to register or qualify such Registrable Securities under such other
securities or blue sky laws of such jurisdictions as such holders reasonably request and do any and
all other acts and things which may be reasonably necessary or advisable to enable such holders to
consummate the disposition in such jurisdictions of the Registrable Securities owned by such
holders; provided, however, that the Company shall not be required to: (i) qualify
generally to do business in any jurisdiction where it would not otherwise be required to qualify
but for this subparagraph, (ii) subject itself to taxation in any such jurisdiction, or (iii)
consent to general service of process in any such jurisdiction;

          (e) notify such holders, at any time when a prospectus relating thereto is required to be
delivered under the Securities Act, of the happening of any event as a result of which the
prospectus included in such registration statement contains an untrue statement of a material fact
or omits any material fact necessary to make the statements therein, in light of the

8

 

circumstances in which they are made, not materially misleading, and, at the reasonable
request of such holders, the Company shall prepare a supplement or amendment to such prospectus so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus
shall not contain an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the circumstances in which they are made, not
materially misleading;

          (f) provide a transfer agent and registrar for all such Registrable Securities not later than
the effective date of such registration statement;

          (g) make available for inspection by any underwriter participating in any disposition pursuant
to such registration statement, and any attorney, accountant or other agent retained by any such
underwriter, all financial and other records, pertinent corporate documents and properties of the
Company, and cause the Company’s officers, directors, managers, employees and independent
accountants to supply all information reasonably requested by any such underwriter, attorney,
accountant or agent in connection with such registration statement;

          (h) otherwise use its best efforts to comply with all applicable rules and regulations of the
SEC, and make available to its security holders, as soon as reasonably practicable, an earnings
statement of the Company, which earnings statement shall satisfy the provisions of Section 11(a) of
the Securities Act and, at the option of the Company, Rule 158 thereunder;

          (i) in the event of the issuance of any stop order suspending the effectiveness of a
registration statement, or of any order suspending or preventing the use of any related prospectus
or suspending the qualification of any Registrable Securities included in such registration
statement for sale in any jurisdiction, the Company shall use its best efforts promptly to obtain
the withdrawal of such order;

          (j) use its best efforts to cause any Registrable Securities covered by such registration
statement to be registered with or approved by such other governmental agencies or authorities as
may be necessary to enable the sellers thereof to consummate the disposition of such Registrable
Securities; and

          (k) if the offering is underwritten, use its best efforts to furnish on the date that
Registrable Securities are delivered to the underwriters for sale pursuant to such registration, an
opinion dated such date of counsel representing the Company for the purposes of such registration,
addressed to the underwriters covering such issues as are customarily addressed in opinions to
underwriters in public offerings and reasonably required by such underwriters.

          8.5 [Intentionally Omitted].

          8.6 Expenses. The Company shall pay all Registration Expenses relating to the
registration and listing obligations set forth in this Section 8, except that the Holder shall be
responsible for the Registration Expenses for the second required registration effected pursuant to
Section 8.2(a). For purposes of this Warrant, the term “Registration Expenses” means: (a) all

9

 

registration, filing and FINRA fees, (b) all reasonable fees and expenses of complying with
securities or blue sky laws, (c) all word processing, duplicating and printing expenses, (d) the
fees and disbursements of counsel for the Company and of its independent public accountants,
including the expenses of any special audits or “cold comfort” letters required by or incident to
such performance and compliance, (e) premiums and other costs of policies of insurance (if any)
against liabilities arising out of the public offering of the Registrable Securities being
registered if the Company desires such insurance, if any, and (f) fees and disbursements of one
counsel for all of the selling holders of Registrable Securities. Registration Expenses shall not
include any underwriting discounts and commissions which may be incurred in the sale of any
Registrable Securities and transfer taxes of the selling holders of Registrable Securities.

          8.7 Restrictions. The Company shall not be obligated to effect a registration
pursuant to Section 8.2 during the period beginning on the date sixty (60) days prior to the
Company’s good faith estimate of the date of filing of, and ending on a date one hundred twenty
(120) days after the effective date of, a Company-initiated registration (other than a registration
pursuant to Form S-8), provided that: (i) if the holder of Registrable Securities elects to have
all or some of its Registrable Securities included in the registration pursuant to Section 8.3
hereof, such Registrable Securities are included in the Company-initiated registration statement to
the extent required hereunder and (ii) the Company is actively employing its best efforts to cause
such registration to become effective.

          8.8 Information Provided by Holders. Any holder of Registrable Securities included in
any registration shall furnish to the Company such information as the Company may reasonably
request in writing to enable the Company to comply with the provisions hereof in connection with
any registration referred to in this Warrant. In the event that a holder of Registrable Securities
fails to provide such information on a timely basis, and in any event within seven (7) Business
Days of the Company’s written request, then the Company shall be entitled to exclude the
Registrable Securities of such holder from such registration and the Company shall nevertheless be
deemed to have satisfied its obligations hereunder with respect to such registration.

     9. Restrictions on Transfer.

          9.1 Restrictive Legends. This Warrant and each Warrant issued upon transfer or in
substitution for this Warrant pursuant to Section 10 hereof, each certificate for Common Shares
issued upon the exercise of the Warrant and each certificate issued upon the transfer of any such
Common Shares shall be transferable only upon satisfaction of the conditions specified in this
Section 9. Each of the foregoing securities shall be stamped or otherwise imprinted with a legend
reflecting the restrictions on transfer set forth herein and any restrictions required under the
Securities Act or other applicable securities laws.

          9.2 Notice of Proposed Transfer. Prior to any transfer of any securities which are
not registered under an effective registration statement under the Securities Act (“Restricted
Securities”), which transfer may only occur if there is an exemption from the registration
provisions of the Securities Act and all other applicable securities laws, the Holder will give
written notice to the Company of the Holder’s intention to effect a transfer (and shall describe

10

 

the manner and circumstances of the proposed transfer). The following provisions shall apply
to any proposed transfer of Restricted Securities:

             
  (i) If in the opinion of counsel for the Holder reasonably satisfactory to the Company the
proposed transfer may be effected without registration of the Restricted Securities under the
Securities Act (which opinion shall state in detail the basis of the legal conclusions reached
therein), the Holder shall, upon delivery of an executed original of such opinion, be entitled to
transfer the Restricted Securities in accordance with the terms of the notice delivered by the
Holder to the Company. Each certificate representing the Restricted Securities issued upon or in
connection with any transfer shall bear the restrictive legends required by Section 9.1 hereof.

             
  (ii) If the opinion called for in (i) above is not delivered, the Holder shall not be entitled
to transfer the Restricted Securities until either (x) receipt by the Company of a further notice
from such Holder pursuant to the foregoing provisions of this Section 9.2 and fulfillment of the
provisions of clause (i) above, or (y) such Restricted Securities have been effectively registered
under the Securities Act.

          9.3 Certain Other Transfer Restrictions. Notwithstanding any other provision of this
Section 9: (i) prior to the Vesting Date, this Warrant or the Restricted Securities thereunder may
only be transferred or assigned to the persons permitted under FINRA Rule 5110(g)(1), and (ii) no
opinion of counsel shall be necessary for a transfer of Restricted Securities by the Holder to any
Person employed by or owning equity in the Holder, if the transferee agrees in writing to be
subject to the terms hereof to the same extent as if the transferee were the original holder hereof
and such transfer is permitted under applicable securities laws.

          9.4 Termination of Restrictions. The restrictions imposed by this Section 9 upon the
transferability of Restricted Securities shall cease and terminate as to any particular Restricted
Securities: (a) which shall have been effectively registered under the Securities Act, or (b) when,
in the opinions of both counsel for the Holder and counsel for the Company, such restrictions are
no longer required to insure compliance with the Securities Act. Whenever such restrictions shall
cease and terminate as to any Restricted Securities, the Holder shall be entitled to receive from
the Company, without expense (other than applicable transfer taxes, if any), new securities of like
tenor not bearing the applicable legends required by Section 9.1 hereof.

     10. Ownership, Transfer and Substitution of Warrant.

          10.1 Ownership of Warrant. The Company may treat any Person in whose name this
Warrant is registered in the Warrant Register maintained pursuant to Section 10.2(b) hereof as the
owner and Holder for all purposes, notwithstanding any notice to the contrary, except that, if and
when any Warrant is properly assigned in blank, the Company may (but shall not be obligated to)
treat the bearer thereof as the owner of such Warrant for all purposes, notwithstanding any notice
to the contrary. Subject to Sections 9 and 10 hereof, this Warrant, if properly assigned, may be
exercised by a new Holder without a new Warrant first having been issued.

11

 

          10.2 Office; Exchange of Warrant.

          (a) The Company will maintain its principal office at the location identified in the
prospectus relating to the Offering or at such other offices as set forth in the Company’s most
current filing under the Securities Exchange Act of 1934, as amended, or as the Company otherwise
notifies the Holder.

          (b) The Company shall cause to be kept at its office a Warrant Register for the registration
and transfer of the Warrant. The name and address of the Holder of the Warrant, the transfers
thereof and the name and address of the transferee of the Warrant shall be registered in such
Warrant Register.

          (c) Upon the surrender of this Warrant, properly endorsed, for registration of transfer or for
exchange at the office of the Company maintained pursuant to Section 10.2(a) hereof, the Company at
its expense will (subject to compliance by the Holder with Section 9 hereof, if applicable) execute
and deliver to or upon the order of the Holder thereof a new Warrant of like tenor, in the name of
such Holder or as such Holder (upon payment by such holder of any applicable transfer taxes) may
direct, calling in the aggregate on the face thereof for the number of Common Shares called for on
the face of the Warrant so surrendered (after giving effect to any previous adjustment(s) to the
number of Warrant Shares).

          10.3 Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such
loss, theft or destruction of this Warrant, upon delivery of indemnity reasonably satisfactory to
the Company in form and amount or, in the case of any mutilation, upon surrender of this Warrant
for cancellation at the office of the Company maintained pursuant to Section 10.2(a) hereof, the
Company, at its expense, will execute and deliver, in lieu thereof, a new Warrant of like tenor and
dated the date hereof.

     11. No Rights or Liabilities as Stockholder. Except as provided in Section 4.4, no
Holder shall be entitled to vote or receive dividends or be deemed the holder of any Common Shares
or any other securities of the Company which may at any time be issuable on the exercise hereof for
any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such,
any of the rights of a stockholder of the Company or any right to vote for the election of
directors or upon any matter submitted to stockholders at any meeting thereof, or to give or
withhold consent to any corporate action (whether upon any recapitalization, issuance of stock,
reclassification of stock, change of par value, consolidation, Merger, conveyance, or otherwise) or
to receive notice of meetings, or to receive dividends or subscription rights or otherwise until
the Warrant shall have been exercised and the Common Shares purchasable upon the exercise hereof
shall have become deliverable, as provided herein. The Holder will not be entitled to share in the
assets of the Company in the event of a liquidation, dissolution or the winding up of the Company.

     12. Notices. Any notice or other communication in connection with this Warrant shall
be given in writing and directed to the parties hereto as follows: (a) if to the Holder, c/o

12

 

Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174, Attn: David Strupp, Fax No: (212)
895-3783 or (b) if to the Company, to the attention of its Chief Executive Officer at its office
maintained pursuant to Section 10.2(a) hereof; provided, that the exercise of the Warrant
shall also be effected in the manner provided in Section 3 hereof. Notices shall be deemed
properly delivered and received when delivered to the notice party (i) if personally delivered,
upon receipt or refusal to accept delivery, (ii) if sent via facsimile, upon mechanical
confirmation of successful transmission thereof generated by the sending telecopy machine, (iii) if
sent by a commercial overnight courier for delivery on the next Business Day, on the first Business
Day after deposit with such courier service, or (iv) if sent by registered or certified mail, five
(5) Business Days after deposit thereof in the U.S. mail.

     13. Payment of Taxes. The Company will pay all documentary stamp taxes attributable
to the issuance of Common Shares underlying this Warrant upon exercise of this Warrant;
provided, however, that the Company shall not be required to pay any tax which may
be payable in respect of any transfer involved in the transfer or registration of this Warrant or
any certificate for Common Shares underlying this Warrant in a name other that of the Holder. The
Holder is responsible for all other tax liability that may arise as a result of holding or
transferring this Warrant or receiving Common Shares underlying this Warrant upon exercise hereof.

     14. Miscellaneous. This Warrant and any term hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the party against which
enforcement of the change, waiver, discharge or termination is sought. This Warrant shall be
construed and enforced in accordance with and governed by the laws of the State of New York. The
section headings in this Warrant are for purposes of convenience only and shall not constitute a
part hereof.

[Signature Page Follows]

13

 

     IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the date
first above written.

	 	 	 	 	 
	 	REGENERX BIOPHARMACEUTICALS, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

[Signature Page to Representative’s Warrant]

14

 

EXHIBIT A

FORM OF EXERCISE NOTICE

[To be executed only upon exercise of Warrant]

To RegeneRx Biopharmaceuticals, Inc.:

          
The undersigned registered holder of the within Warrant hereby irrevocably exercises the
Warrant pursuant to Section 3.1 of the Warrant with respect to            
          Warrant Shares, at an
exercise price per share of $___, and requests that the certificates for such Warrant Shares be
issued, subject to Sections 9 and 10, in the name of, and delivered to:

	 	 	 	 	 

	 

	 	 

	 	 
	 
	 	 	 	 
	 

	 	 

	 	 
	 
	 	 	 	 
	 

	 	 

	 	 
	 
	 	 	 	 
	 

	 	 

	 	 

          
The undersigned is hereby making payment for the Warrant Shares in the following manner:
                     
                    [describe desired payment method as provided for in 3.1 of the Warrant].

          
The undersigned  hereby represents and warrants that it is, and has been since its acquisition
of the Warrant, the record and beneficial owner of the Warrant.

Dated:            
         

	 	 	 	 	 

	 

	 	 	 	 
	 

	 	Print or Type Name	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 	 	(Signature must conform in all respects to name of holder as specified on the face of Warrant)
	 
	 	 	 	 
	 

	 	 	 	 
	 

	 	(Street Address)	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 

	 	(City)       (State)      (Zip Code)	 	 

 

EXHIBIT B

FORM OF ASSIGNMENT

[To be executed only upon transfer of Warrant]

          For value
received, the undersigned registered holder of the within Warrant hereby sells,
assigns, and transfers unto                  
                     
   [include name and addresses] the rights
represented by the Warrant to purchase                
      Common Shares of RegeneRx Biopharmaceuticals,
Inc. to which the Warrant relates, and appoints              
                     
       Attorney to make such
transfer on the books of RegeneRx Biopharmaceuticals, Inc. maintained for the purpose, with full
power of substitution in the premises.

	 	 	 

	Dated:

	 	 
	 

	 	(Signature must conform in all respects
	 

	 	to name of holder as specified on the
	 

	 	face of Warrant)
	 
	 	 
	 

	 	(Street Address)
	 
	 	 
	 

	 	(City) (State) (Zip Code)
	 
	 	 
	Signed in the presence of:

	 	 
	 
	 	 
	 

	 	(Signature of Transferee)
	 
	 	 
	 

	 	(Street Address)
	 
	 	 
	 

	 	(City) (State) (Zip Code)
	Signed in the presence of:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}]]